These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4730881)

  • 1. Interaction between debrisoquine and phenylephrine in man.
    Allum W; Aminu J; Bloomfield TH; Davies C; Scales AH; Vere DW
    Br J Pharmacol; 1973 Mar; 47(3):675P-676P. PubMed ID: 4730881
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials with Tendor (debrisoquine sulfate).
    Langer L; Gerö A
    Ther Hung; 1974; 22(4):165-71. PubMed ID: 4465961
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between debrisoquine and phenylephrine.
    Aminu J; D'Mello A; Vere DW
    Lancet; 1970 Oct; 2(7679):935-6. PubMed ID: 4097321
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: A correlation between the response to debrisoquine and the amount of unchanged drug excreted in the urine.
    Angelo M; Dring LG; Lancaster R; Latham A; Smith RL
    Br J Pharmacol; 1975 Oct; 55(2):264P. PubMed ID: 1201404
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the hypotensive effect of debrisoquin sulfate (Declinax)].
    Honorato F; Ortolá RP
    Rev Med Univ Navarra; 1973 Dec; 17(4):339-44. PubMed ID: 4807215
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperpyrexic interaction between debrisoquine and pethidine in rabbits.
    Osman OH; Eltayeb IB
    J Pharm Pharmacol; 1977 Mar; 29(3):143-6. PubMed ID: 15077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive response to debrisoquine and hydroxylation phenotype.
    Idle JR; Mahgoub A; Lancaster R; Smith RL
    Life Sci; 1978 Mar; 22(11):979-83. PubMed ID: 642709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term treatment of hypertension with debrisoquin sulfate].
    Hammarström S
    Lakartidningen; 1970 Jun; 67(23):2663-8. PubMed ID: 5450560
    [No Abstract]   [Full Text] [Related]  

  • 10. A longitudinal study of the mechanisms of action of debrisoquine and propranolol.
    Aminu J; Vere DW
    Br J Clin Pharmacol; 1978 Jul; 6(1):43-50. PubMed ID: 352376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of biochemical and hypotensive effects of debrisoquine in hypertensive patients.
    Silas JH; Jones J; Tucker GT; Townshend MM; Phillips CA; Smith AJ
    Eur J Clin Pharmacol; 1979 Sep; 16(2):81-6. PubMed ID: 499312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Parasympathetic blockade in patients treated with debrisoquine and with propranolol.
    Aminu J
    West Afr J Pharmacol Drug Res; 1974 Dec; 2(1):53P-54P. PubMed ID: 4470635
    [No Abstract]   [Full Text] [Related]  

  • 13. On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin.
    Medina MA; Giachetti A; Shore PA
    Biochem Pharmacol; 1969 Apr; 18(4):891-901. PubMed ID: 5788526
    [No Abstract]   [Full Text] [Related]  

  • 14. Concentration of debrisoquine by human platelets in vivo: relationship to hypotensive effect [proceedings].
    Lennard MS; Silas JH; Smith AJ; Tucker GT
    Br J Clin Pharmacol; 1977 Oct; 4(5):635P. PubMed ID: 911620
    [No Abstract]   [Full Text] [Related]  

  • 15. [A study on the hypotensive action and mechanism of berbamine hydrochloride (author's transl)].
    Zhou ZD; Han CH; Wang P
    Yao Xue Xue Bao; 1980 Apr; 15(4):248-50. PubMed ID: 7457144
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of intravenous tyramine and the cold pressor test to help elucidate a possible mechanism of action of a new isoquinoline compound shown to have antihypertensive properties in humans.
    Pocelinko R; Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):13-9. PubMed ID: 4896482
    [No Abstract]   [Full Text] [Related]  

  • 17. The hypotensive effect of dauricine and its mechanism of action.
    Chen SH; Hu CJ
    Acta Acad Med Wuhan; 1983; 3(2):125-7. PubMed ID: 6866387
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hydrocortisone on phenylephrine--mean arterial pressure dose-response relationship in septic shock.
    Bellissant E; Annane D
    Clin Pharmacol Ther; 2000 Sep; 68(3):293-303. PubMed ID: 11014411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation by rat vas deferens of debrisoquine and guanoxan.
    Shah DS; Premanand N; Jariwala NU; Gulati OD
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):41-50. PubMed ID: 4811458
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of hypotensive effect of debrisoquine by insulin.
    Hume L
    Diabet Med; 1985 Sep; 2(5):390-1. PubMed ID: 2951097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.